Media centre

Press releases

To be notified when a new press release is added to this site please register with our alert service.

•  2008 
•  2007 
•  2006 
•  2005 
•  2004 
•  2003 
•  2002 

Date	Title
20/12/2007	Antisoma opens US Headquarters in Princeton, New Jersey
10/12/2007	ASH presentation supports Antisoma's AS1411 phase II trial in AML
26/11/2007	Antisoma to present at Piper Jaffray and Lazard Capital Markets conferences
20/11/2007	Antisoma AGM update and Interim Management Statement
05/11/2007	Antisoma to present at CIBC and Rodman & Renshaw conferences
15/10/2007	Antisoma encouraged by ASA404 prostate cancer data
12/09/2007	Antisoma’s preliminary results for the year ended 30 June 2007
05/09/2007	Positive survival data from ASA404 trial presented at World Conference on Lung Cancer
22/08/2007	Antisoma’s ASA404 1800 mg/m2 lung cancer trial will report positive survival data
06/08/2007	Antisoma starts phase II trial of AS1411 in acute myeloid leukaemia
12/07/2007	Antisoma announces further data from ASA404 ovarian cancer trial
07/06/2007	Antisoma receives USD 75 million following successful completion of ASA404 licensing agreement
03/06/2007	Positive data from ASA404 prostate cancer trial presented at ASCO
25/05/2007	Antisoma announces EGM results and updates on timing of AS1404 data
19/04/2007	Antisoma announces global agreement with Novartis for cancer drug AS1404
19/04/2007	Antisoma strategy update – joint statement from the Chairman and CEO
16/04/2007	Data supporting three Antisoma programmes presented at AACR
08/03/2007	Second lung cancer trial adds to positive data on AS1404
23/02/2007	Positive AS1404 trial data presented at ASCO Prostate Cancer Symposium
15/02/2007	Antisoma plc reports half-year results